---
title: Aprepitant
category: drug
feed: show
date: 16-05-2023
tags: Drug 
author: Dragoman
---

## Mechanism of Action [^1]
- Aprepitant is a  neurokinin-1 (NK1) receptor antagonist. NK receptors in the brain are involved in nausea.

## Pharmacology [^1]
- **Half-life:** Approximately 40 hours
## Indications [^1]
- Very effective in reducing the incidence of [[Post-operative Nausea and Vomiting]]
## Dosage [^1]
- 40 mg or 80 mg (only 80 mg formulation is available in Calgary)

## Complications [^2]
- In patients receiving hormonal contraceptive therapy, alternative contraception should be used for 1 month following administration. 
- 
## References
[^1]: Tong J. Gan, Kumar G. Belani, Sergio Bergese, Frances Chung, Pierre Diemunsch, Ashraf S. Habib, Zhaosheng Jin, Anthony L. Kovac, Tricia A. Meyer, Richard D. Urman, Christian C. Apfel, Sabry Ayad, Linda Beagley, Keith Candiotti, Marina Englesakis, Traci L. Hedrick, Peter Kranke, Samuel Lee, Daniel Lipman, Harold S. Minkowitz, John Morton, Beverly K. Philip. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting, 2020.
[^2]: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021549s015lbl.pdf
